Bioengineered Skin Sealants
生物工程皮肤密封剂
基本信息
- 批准号:10053067
- 负责人:
- 金额:$ 39.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAnimalsAnti-Bacterial AgentsAreaBindingBiochemicalBiologicalBiological AssayBiomechanicsBiomedical EngineeringBiopsyCharacteristicsCicatrixClinicalColony-forming unitsCommunity HospitalsConsumptionCorrelation StudiesCyanoacrylatesDermabondDermalDrug Delivery SystemsDrug or chemical Tissue DistributionDrug usageDyesEvaluationExcisionFamily suidaeFibrinFormulationGluesGoldHeterogeneityHistamine ReceptorHistologyHistopathologyHumanImageImmunocompetentImmunohistochemistryIn VitroInbred BALB C MiceIndocyanine GreenInfectionInfection ControlInvestigationInvestigational TherapiesLacerationLasersLeadLesionLightLiquid substanceMapsMediator of activation proteinMethodsModelingMusNylonsOperative Surgical ProceduresPatientsPerformancePharmaceutical PreparationsPlayPreventionPropertyProteinsRecoveryResearchRoleSCID MiceSerpinsSilkSiteSkinSkin TissueSkin graftSkin repairSpine surgeryStaphylococcus aureus infectionSurgical Wound InfectionSurgical incisionsSurgical suturesTensile StrengthThickTimeTissuesToxic effectTranslatingTraumaTraumatic injuryUltrasonographyVancomycinVisualizationWaterWound Infectionbiomaterial compatibilitychronic woundcombatdigital imaginghealingimmunoregulationimprovedin vivo evaluationinfrared microscopymethicillin resistant Staphylococcus aureusmortality riskmouse modelnanoparticlenanorodnovelnovel strategiespathogenphotoacoustic imagingrepairedsealskin woundsmall moleculesoft tissuetherapeutic proteintissue repairtissue traumawound
项目摘要
Abstract
Effective approximation, repair, and healing of soft tissues is a significant challenge in trauma and most cases
require rapid, liquid-tight sealing of dermal tissue, which aids fast recovery of tissue biomechanical properties
and resists infections. Sutures and staples are commonly used but do not lead to immediate sealing, cause
significant tissue trauma, are prone to infection, leave characteristic scars and / or suffer from poor cosmesis,
especially in visible areas. Glues, including cyanoacrylate and fibrin, typically result in poor biomechanical
recoveries, can be cumbersome to apply, and / or suffer from formulation-dependent toxicities, which limits their
application only to superficial use in humans. Laser-activated nanoglues (LANGs) that use non-ionizing light,
integrate with tissue to rapidly provide a flight-tight seal, result in better biomechanical recoveries of soft tissues,
and demonstrate better cosmesis profiles are attractive alternatives for dermal sealing and repair. The efficacy
of LANGs, formulated using silk protein and near infrared light-absorbing nanoparticles (e.g. gold nanorods) or
dyes (e.g. indocyanine green), will be investigated for sealing full thickness wounds in live animals.
Biomechanical and biochemical characterization will be carried out in order to investigate the efficacy and
biocompatibility of LANGs compared to sutures and conventional glues; a combination of LANGs with sutures
will also be investigated as a combination approach for enhanced efficacy. In early stages of recovery, sealed
tissue is vulnerable and slow healing can lead to complications including surgical-site infections. Small-molecule
and protein therapeutics will be formulated with LANGs in order to accelerate closure and repair of dermal
incisional wounds particularly at earlier times. Efficacy of LANG sealing and other approximation methods (e.g.
sutures) will be visualized using hyperspectral and photoacoustic imaging of the wound site, and the
heterogeneity of tissue strain, visualized using digital image correlation, will be investigated as an indicator of
potential scarring. A comprehensive picture of LANG-facilitated tissue sealing will thus be generated using a
combination of imaging, biomechanical, and biochemical analyses. Wound infections affect up to 500,000 lives
each year, and are associated with a greater risk of death compared to patients without infection. LANGs will be
formulated with antibacterial drugs in order to simultaneously seal wounds, engender accelerated repair and
combat methicillin-resistant S. aureus (MRSA), which is the most common pathogen in community hospitals.
Our research will lead to novel, multifunctional LANGs that demonstrate high efficacy for sealing, delivery of
drugs for accelerating closure and early-stage repair, and combat infections. We anticipate that LANGs will be
translated particularly in applications where rapid dermal sealing and accelerated repair are desired, sutures and
staples have limited efficacy, infection control is critical and / or where there is a need for improved cosmesis
performance.
抽象的
软组织的有效接近、修复和愈合是创伤和大多数情况下的重大挑战
需要快速、液密密封真皮组织,这有助于组织生物力学特性的快速恢复
并抵抗感染。缝合线和U形钉很常用,但不会立即密封,导致
严重的组织创伤,容易感染,留下特征性疤痕和/或美观不佳,
尤其是在可见区域。胶水,包括氰基丙烯酸酯和纤维蛋白,通常会导致生物力学性能较差
回收率,应用起来可能很麻烦,和/或遭受配方依赖性毒性,这限制了它们
仅适用于人类的表面使用。使用非电离光的激光激活纳米胶(LANG),
与组织结合,快速提供密封,使软组织更好地恢复生物力学,
并证明更好的美容效果是真皮密封和修复的有吸引力的替代方案。功效
LANG,使用丝蛋白和近红外光吸收纳米粒子(例如金纳米棒)配制而成,或
将研究染料(例如吲哚菁绿)用于密封活体动物的全层伤口。
将进行生物力学和生化表征,以研究功效和
与缝合线和传统胶水相比,LANG 的生物相容性; LANG 与缝合线的组合
还将作为增强功效的组合方法进行研究。在恢复的早期阶段,密封
组织脆弱且愈合缓慢可能导致手术部位感染等并发症。小分子
蛋白质疗法将与 LANG 一起配制,以加速真皮的闭合和修复
切伤,尤其是在早期。 LANG 密封和其他近似方法(例如
缝合线)将使用伤口部位的高光谱和光声成像进行可视化,并且
使用数字图像相关性可视化的组织应变的异质性将作为以下指标进行研究:
潜在的疤痕。因此,将使用 LANG 促进的组织封闭生成全面的图片
成像、生物力学和生化分析的结合。伤口感染影响多达 50 万人的生命
每年,与未感染的患者相比,与更高的死亡风险相关。 LANG 将是
采用抗菌药物配制,以同时密封伤口、加速修复和
对抗耐甲氧西林金黄色葡萄球菌 (MRSA),这是社区医院最常见的病原体。
我们的研究将带来新颖的多功能 LANG,这些 LANG 具有密封、输送的高效能
用于加速闭合和早期修复以及对抗感染的药物。我们预计 LANG 将
特别是在需要快速真皮密封和加速修复的应用中,缝合线和
钉书钉的功效有限,感染控制至关重要和/或需要改善美容效果
表现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kaushal Rege其他文献
Kaushal Rege的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kaushal Rege', 18)}}的其他基金
Near Infrared Light Activated Adhesives for Nerve Repair
用于神经修复的近红外光激活粘合剂
- 批准号:
10436799 - 财政年份:2021
- 资助金额:
$ 39.5万 - 项目类别:
Laser-Activated Nanoglues for the prevention and control of surgical site infections
激光激活纳米胶用于预防和控制手术部位感染
- 批准号:
10249234 - 财政年份:2020
- 资助金额:
$ 39.5万 - 项目类别:
DEVELOPMENT OF NOVEL AMINOGLYCOSIDE POLYMERS AND NANOPARTICLES FOR NUCLEIC ACID DELIVERY IN CHRONIC WOUNDS
开发用于慢性伤口核酸输送的新型氨基糖苷聚合物和纳米颗粒
- 批准号:
10009545 - 财政年份:2020
- 资助金额:
$ 39.5万 - 项目类别:
Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics Methods
使用组合和化学信息学方法设计 DNA 递送聚合物
- 批准号:
8602837 - 财政年份:2011
- 资助金额:
$ 39.5万 - 项目类别:
Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics Methods
使用组合和化学信息学方法设计 DNA 递送聚合物
- 批准号:
8212217 - 财政年份:2011
- 资助金额:
$ 39.5万 - 项目类别:
Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics Methods
使用组合和化学信息学方法设计 DNA 递送聚合物
- 批准号:
8416396 - 财政年份:2011
- 资助金额:
$ 39.5万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 39.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 39.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




